Tabuac, Leny M.
HRN: 22-28-94 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/30/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
11/30/2022
12/02/2022
IV
500mg
Q8
MSAF
Waiting Final Action